Experience of Using Genetically Engineered Insulin Preparations Produced by Farmak Company in Patients with Diabetes Mellitus Type 2

Experience of Using Genetically Engineered Insulin Preparations Produced by Farmak Company in Patients with Diabetes Mellitus Type 2

The article deals with one of the most urgent and important socio-economic problems of clinical endocrinology — diabetes mellitus (DM). With the progression of DM, it is harder to control the disease; in this regard, insulin provides additional benefits. The findings of the study on the long-term ef...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Miz︠h︡narodnyĭ endokrynolohichnyĭ z︠h︡urnal 2014-08, Vol.10 (5.61), p.69-74
Hauptverfasser: V.L. Orlenko, A.S. Yefimov, K.Yu. Ivaskiva
Format: Artikel
Sprache:eng
Schlagworte:
diabetes mellitus
Farmasulin
insulin therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The article deals with one of the most urgent and important socio-economic problems of clinical endocrinology — diabetes mellitus (DM). With the progression of DM, it is harder to control the disease; in this regard, insulin provides additional benefits. The findings of the study on the long-term efficacy and tolerability of all types of Farmasulin preparations in patients with diabetes mellitus type 2 are provided.
ISSN:2224-0721
2307-1427
DOI:10.22141/2224-0721.5.61.2014.76858